EBRO 2017

Contralateral Breast Cancer

50

p=0.001 P<0.001 P<0.0001 P<0.0001 P<0.0001

40

BRCA 1/2 Controls

30

%

20

10

0

Yale 10 yrs.

Curie 10 yrs.

Rotterdam 5 yrs.

Multicentric 10 yrs.

Memorial/McGill 10 yrs.